Kolexia
Kerbrat Anne
Neurologie
Hôpital Pontchaillou
Rennes, France
86 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Sclérose en plaques Sclérose Sclérose en plaques récurrente-rémittente Sclérose en plaques chronique progressive Maladies démyélinisantes Neuromyélite optique Maladie aigüe Leucoencéphalopathie multifocale progressive Leucoencéphalopathies

Industries

Merck-Serono
6 collaboration(s)
Dernière en 2023
Edimark
4 collaboration(s)
Dernière en 2021
Biogen
2 collaboration(s)
Dernière en 2022
Sanofi
1 collaboration(s)
Dernière en 2022

Dernières activités

INFLANET: A French Network for PET Imaging of Neuroinflammation in MS
Essai Clinique (Assistance publique – Hôpitaux de Paris)   19 février 2024
Cancer and multiple sclerosis: 2023 recommendations from the French Multiple Sclerosis Society.
Multiple sclerosis (Houndmills, Basingstoke, England)   15 février 2024
VHD cohort: Very High Definition Cohort: Assessment of New Prognostic Biomarkers of Disability Worsening in a Multicenter Cohort of MS Patients by Imaging, Optical Coherence Tomography and Biology
Essai Clinique (EDMUS Foundation)   15 février 2024
Highly Effective Therapies as First-Line Treatment for Pediatric-Onset Multiple Sclerosis.
JAMA neurology   12 février 2024
STOP-I-SEP: Disease Modifying Therapies Withdrawal in Inactive Secondary Progressive Multiple Sclerosis Patients Older Than 50 Years
Essai Clinique (CHU Rennes)   23 octobre 2023
TOTEM-RRMS: TOTEM RRMS : TestOsterone TreatmEnt on Neuroprotection and Myelin Repair in Relapsing Remitting Multiple Sclerosis
Essai Clinique (Grünenthal)   23 octobre 2023
Impact of automatic tools for detecting new lesions on therapeutic strategies offered to patients with MS by neurologists.
Multiple sclerosis and related disorders   20 octobre 2023
Effectiveness of regional diffusion MRI measures in distinguishing multiple sclerosis abnormalities within the cervical spinal cord.
Brain and behavior   29 septembre 2023
MAP-MS: Motor Asymmetry in Progressive Multiple Sclerosis Patients
Essai Clinique (CHU Rennes)   25 avril 2023
Switching from natalizumab administration at the day hospital to administration at home. A 1 year prospective study of patient experience and quality of life in 30 consecutive patients with multiple sclerosis (TYSAD-35).
Multiple sclerosis and related disorders   23 mars 2023